ACCESSWIRE
12 May 2022, 16:25 GMT+10
GOTHENBURG, SE / ACCESSWIRE / May 12, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)
Machine perfusion for lungs and livers is now being reimbursed in the Dutch healthcare system. The Netherlands has a pronounced evidence-based healthcare system. Therefore, if a treatment option is proven beneficial for patients the government is likely to approve reimbursement. Several clinical trials conducted by world-renowned clinicians served as a foundation for the Dutch Ministry of Health's decision. XVIVO's technologies were used in those clinical trials.
Reducing post-transplant complications is an important objective for every transplant team. Combining traditional static cold preservation with machine perfusion before transplantation has shown to improve organ quality and thereby increase patient well-being. In a recent article in NEJM[1], using the dHOPE protocol with XVIVO's machine perfusion technology for DCD (Donation after Circulatory Death) livers demonstrated a decrease in post-transplant complications.
'Machine perfusion for kidneys was already reimbursed in the Netherlands, and now it makes me very happy that also lungs and livers are included. XVIVO's machine perfusion technology for lungs has been on the Dutch market for 8 years and is used at all lung transplant centers. The perfusion technology for livers has been available for 10 years and is used at every liver transplant center throughout the country' says Mark Slotemaker, Regional Business Manager Abdominal, Benelux and DACH, XVIVO.
'Patients always deserve the best. By countries widening their reimbursement systems more patients can get a lifesaving transplant. XVIVO's technologies for machine perfusion have on many occasions proven to be one of the important reasons behind countries broadening their reimbursement criteria, which makes me very proud. We come to work every day because ‘nobody should die waiting for a new organ', and therefore I am very pleased to see the positive development in the Netherlands', says Dag Andersson, CEO of XVIVO.
Dag Andersson, CEO
XVIVO Perfusion AB (publ)
[1] van Rijn R, et al. Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial. N Engl J Med. 2021; 384:1391-1401.
For further information, please contact:
Dag Andersson, CEO, +46 76 643 30 31, e-mail: dag.andersson@xvivogroup.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com
About Us
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.
Attachments
SOURCE: XVIVO Perfusion AB
Get a daily dose of Boston Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Boston Star.
More InformationNEW DELHI, India: Skyroot, India's first privately held company to design, build and test a solid rocket propulsion system, successfully ...
SYDNEY, NSW, Australia - Stocks in Asia were mostly moderately higher at the close Monday, while the U.S. dollar was ...
BEIJING, China: Chinese consumers have been vocal in their criticism of a $1,373 Gucci umbrella which should be kept out ...
STUTTGART, Germany: Beginning in 2025, Mercedes-Benz will incorporate a new, highly energy-dense battery in its G-Class electric vehicles, potentially solving ...
LONDON, England: UK prices are rising at their fastest rate in 40 years, as higher energy bills are changing spending ...
MINNEAPOLIS, Minnesota: Amidst the rising costs of essentials, such as fuel and food, and the rapid return by consumers to ...
After Marco Gonzales stymied the Toronto Blue Jays last week, allowing one run in six innings, Seattle Mariners manager Scott ...
One by-product of carrying the youngest roster in the majors is the occasional defensive lapse that proves costly, and for ...
Mumbai (Maharashtra) [India], May 23 (ANI): No case of Monkeypox has been reported in Mumbai so far, Brihanmumbai Municipal Corporation ...
Manny Machado had four extra-base hits in a game for the first time in his career and rookie left-hander MacKenzie ...
The Dallas Fuel and Atlanta Reign made big moves up the West division standings by feasting on bottom feeders Sunday ...
OpTic Texas stayed unbeaten in three matches and took sole possession of second place Sunday as Week 2 concluded in ...